Characteristic | Survivors (n = 135 ) | Non-survivors (n = 39 ) | All patients (n = 174) | P value |
---|---|---|---|---|
Postnatal age, days | 7 (1–27) | 11 (1–27) | 8 (1–27) | 0.001* |
Female sex | 62 (45.9%) | 16 (41%) | 78 (45%) | 0.59 |
Weight, kg | 2.73 ± 0.58 | 2.46 ± 0.71 | 2.66 ± 0.62 | 0.022* |
Gestational age, week | 38 (35–40) | 37 (35–42) | 37.5 (35–42) | 0.25 |
Preterm | 34 (25.2%) | 15 (38.5%) | 49 (28.2%) | 0.1 |
Full term | 101 (74.8%) | 24 (61.5%) | 125 (71.8%) | |
Cesarean delivery | 108 (80%) | 33 (84.6%) | 141 (81%) | 0.52 |
Early-onset sepsis | 37 (27.4%) | 8 (20.5%) | 45 (25.8%) | 0.39 |
Late-onset sepsis | 98 (72.6%) | 31 (79.5%) | 129 (74.1%) | |
Proven sepsis | 47 (34.8%) | 26 (66.7%) | 73 (42%) | < 0.001* |
Possible sepsis | 88 (65.2%) | 13 (33.3) | 101 (58%) | |
Invasive mechanical ventilation | 76 (56.3%) | 35 (89.7%) | 111 (63.8%) | < 0.001* |
Type of organism | 0.48 | |||
Gram positive | 14 (10.4%) | 5 (12.8%) | 19 (10.9%) | |
Gram negative | 29 (21.5%) | 17 (43.6%) | 46 (26.4%) | |
Candida | 4 (3%) | 4 (10.3%) | 8 (4.6%) | |
Glycemic status | 0.024* | |||
High | 14 (10.4%) | 8 (20.5%) | 22 (12.6%) | |
Low | 10 (7.4%) | 9 (23.1%) | 19 (10.9%) | |
Normal | 111 (82.2%) | 22 (56.4%) | 133 (76.4%) | |
CRP, mg/dL | 27 (0–289) | 77 (2–316) | 47 (0–316) | 0.015* |
WBC (× 1000/mL) | 12.9 (2.7–51) | 11.5 (2.7–50) | 12.6 (2.7–51) | 0.32 |
Platelets (× 1000/mL) | 162 (5–648) | 40 (4–676) | 141 (4–676) | < 0.001* |
Hemoglobin, g/dL | 12.84 ± 3.11 | 11.73 ± 2.51 | 12.6 ± 3.01 | 0.042* |
Creatinine, mg/dL | 0.6 (0.2–2.7) | 0.6 (0.16–1.2) | 0.6 (0.16–2.7) | 0.89 |